List of diseases covered by
Severe Combined Immunodeficiency NGS panel
Gene | Condition |
ADA | Severe combined immunodeficiency due to ADA deficiency |
AK2 | Reticular dysgenesis |
CARD11 | B-cell expansion with NFKB and T-cell anergy; Immunodeficiency 11A; Immunodeficiency 11B with atopic dermatitis |
CD247 | Immunodeficiency 25 |
CD40 | Immunodeficiency with hyper-IgM, type 3 |
CD8A | CD8 deficiency, familial |
CD3D | Immunodeficiency 19 |
CD3E | Immunodeficiency 18, SCID variant |
CD3G | Immunodeficiency 17, CD3 gamma deficient |
CD40LG | Immunodeficiency, X-linked, with hyper-IgM |
CIITA | Bare lymphocyte syndrome, type II, complementation group A; Rheumatoid arthritis, susceptibility to |
CORO1A | Immunodeficiency 8 |
DCLRE1C | Severe combined immunodeficiency, Athabascan type; Omenn syndrome |
DOCK8 | Hyper-IgE recurrent infection syndrome, autosomal recessive |
FOXN1 | T-cell immunodeficiency, congenital alopecia, and nail dystrophy; T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant |
IKBKB | Immunodeficiency 15A; Immunodeficiency 15B |
IL7R | Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type |
IL2RA | Immunodeficiency 41 with lymphoproliferation and autoimmunity |
IL2RG | Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked |
JAK3 | SCID, autosomal recessive, T-negative/B-positive type |
LCK | Immunodeficiency 22 |
LIG4 | LIG4 syndrome |
MALT1 | Immunodeficiency 12 |
MTHFD1 | Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia |
NHEJ1 | Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation |
ORAI1 | Immunodeficiency 9; Myopathy, tubular aggregate, 2 |
PGM3 | Immunodeficiency 23 |
PNP | Immunodeficiency due to purine nucleoside phosphorylase deficiency |
PRKDC | Immunodeficiency 26, with or without neurologic abnormalities |
PTPRC | Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive |
RAC2 | Immunodeficiency 73C with defective neutrophil chemotaxis and hypogammaglobulinemia; Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis; Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia |
RAG1 | Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity; Omenn syndrome; Combined cellular and humoral immune defects with granulomas; Severe combined immunodeficiency, B cell-negative |
RAG2 | Combined cellular and humoral immune defects with granulomas; Omenn syndrome; Severe combined immunodeficiency, B cell-negative |
RFX5 | Bare lymphocyte syndrome, type II, complementation group C |
RFXANK | MHC class II deficiency, complementation group B |
RFXAP | Bare lymphocyte syndrome, type II, complementation group D |
RMRP | Anauxetic dysplasia 1; Cartilage-hair hypoplasia; Metaphyseal dysplasia without hypotrichosis |
SLC46A1 | Folate malabsorption, hereditary |
STAT5B | Growth hormone insensitivity with immune dysregulation 1, autosomal recessive; Growth hormone insensitivity with immune dysregulation 2, autosomal dominant |
STIM1 | Immunodeficiency 10; Myopathy, tubular aggregate, 1; Stormorken syndrome |
TBX1 | Conotruncal anomaly face syndrome; DiGeorge syndrome; Tetralogy of Fallot; Velocardiofacial syndrome |
TTC7A | Gastrointestinal defects and immunodeficiency syndrome |
UNC119 | Immunodeficiency 13 |
ZAP70 | Immunodeficiency 48; Autoimmune disease, multisystem, infantile-onset, 2 |